Lichenoid Eruption Associated with the Use of Nebivolol

Abstract

Nebivolol can cause LDE, as has been reported with other beta-blockers. The underlying mechanism appears to be T cell-mediated. Cross-reactivity with other beta-blockers cannot be excluded; therefore, the risk of recurrent LDE should be weighed carefully against the clinical benefit before switching to another beta-blocker.